© 2026 MergersCorp M&A International.
is a global brand operating through a number of professional firms and constituent entities located throughout the world to provide M&A Advisory and other client related professional services. The Member Firms are constituted and regulated in accordance with relevant local regulatory and legal requirements. For more details on the nature of our affiliation, please visit us on our website https://dev.cherrycoding.com/mergerscorp/disclaimer. MergersCorp M&A International is not a registered broker-dealer under the U.S. securities laws.
This website does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation of any security or any other product or service by MergersUS Inc. or any other third party regardless of whether such security, product or service is referenced in this website. Furthermore, nothing in this website is intended to provide tax, legal, or investment advice and nothing in this website should be construed as a recommendation to buy, sell, or hold any investment or security or to engage in any investment strategy or transaction.MergersCorp M&A International franchising program is not offered to individuals or entities located in the United States
The franchising program is offered by MergersUK Limited a UK Company with registered office at 71-75 Shelton Street, Covent Garden, London, WC2H 9JQ, United Kingdom
独一无二的机会,收购一个在欧盟跨境框架下运营、规模迅速扩大、完全远程远程医疗和数字处方、符合 GDPR 标准的平台。 该业务将 20,000 多名患者与德国的执业医生和药房联系起来
在欧盟跨境远程医疗框架下运营(在德国和波兰获得执照的医生)。 符合 GDPR 的平台。 无需大麻直接处理许可证。
总部位于塞浦路斯的公司运营着一个完全数字化的远程医疗平台,实现远程会诊和数字处方
该平台于 2024 年启动,目前已为约 20,000 名患者提供服务,每月处理超过 6,500 份处方
在启动 Facebook 广告和联属营销等目标营销活动之前,专注于深度流程优化以确保可扩展性,并继续实施新功能以提升用户体验
业务盈利,利润率超过 60%,目前每月收入约为 14 万欧元,预计到年底将达到 150 万欧元,年增长率约为 20
收入来自病人预约、药房营销服务、与主要生产商的合作以及白标产品。
利用前端和后端自由职业专家,与约 12 名员工/自由职业者高效运作
自动工作流程可将医生问诊时间缩短 90%,平台支持白标功能,可快速扩展 B2B 业务
预计年增长率为 15-20%,这主要得益于患者需求的增长和德国大麻市场近期的开放
寻求全面出售,包括持续经营业务、知识产权、品牌、患者数据库和软件代码库
© 2025 MergersCorp M&A International is a global brand operating through a number of professional firms and constituent entities (“Members”) located throughout the world to provide Investment Banking, Corporate Finance, and Advisory Services and other client-related professional services. The Member Firms (“Members”) are constituted and regulated in accordance with relevant local regulatory and legal requirements. For more details on the nature of our affiliation, please visit our Disclaimer: https://mergerscorp.com/disclaimer. MergersCorp M&A International's franchising program is not offered to individuals or entities located in the United States.
The franchising program is offered by MergersUK Limited, a UK Company with its registered office at 71-75 Shelton Street, Covent Garden, London, WC2H 9JQ, United Kingdom.
MergersCorp M&A International provides strategic business advisory services, including preparing companies for growth and capital access. Through partnerships with licensed investment bankers, clients can access tailored capital-raising solutions.
U.S. Investment Banking Securities transactions are exclusively conducted by Spektrum Capital Advisors LLC, a Registered Representative of, and Securities Products offered through, BA Securities, LLC, a FINRA-registered broker-dealer. Check the background of investment professionals associated with this site on Broker Check.
This website is operated by MergersUS Inc a US Corporation with registered office at





描述
独一无二的机会,收购一个在欧盟跨境框架下运营、规模迅速扩大、完全远程远程医疗和数字处方、符合 GDPR 标准的平台。 该业务将 20,000 多名患者与德国的执业医生和药房联系起来
持有的许可证
在欧盟跨境远程医疗框架下运营(在德国和波兰获得执照的医生)。 符合 GDPR 的平台。 无需大麻直接处理许可证。
列表详情
总部位于塞浦路斯的公司运营着一个完全数字化的远程医疗平台,实现远程会诊和数字处方
该平台于 2024 年启动,目前已为约 20,000 名患者提供服务,每月处理超过 6,500 份处方
在启动 Facebook 广告和联属营销等目标营销活动之前,专注于深度流程优化以确保可扩展性,并继续实施新功能以提升用户体验
业务盈利,利润率超过 60%,目前每月收入约为 14 万欧元,预计到年底将达到 150 万欧元,年增长率约为 20
收入来自病人预约、药房营销服务、与主要生产商的合作以及白标产品。
利用前端和后端自由职业专家,与约 12 名员工/自由职业者高效运作
自动工作流程可将医生问诊时间缩短 90%,平台支持白标功能,可快速扩展 B2B 业务
预计年增长率为 15-20%,这主要得益于患者需求的增长和德国大麻市场近期的开放
寻求全面出售,包括持续经营业务、知识产权、品牌、患者数据库和软件代码库
Basic Details
Target Price:
$ 0
Gross Revenue
$1,680,000
EBITDA
$1,008,000
Business ID:
L#20261003
Country
塞浦路斯
详情
Similar Businesses
Published on 9 3 月, 2026 在 12:33 下午. 更新 9 3 月, 2026 在 12:33 下午
加拿大以退伍军人为重点的盈利性虚拟医用大麻诊所
待定
医疗保健业务
PREVIOUS PROPERTY
阿克托别油田重建的底土使用权(150 万吨 B+C1)
NEXT PROPERTY
加拿大以退伍军人为重点的盈利性虚拟医用大麻诊所